Comparison of the Efficacy and Safety of a Doravirine-Based, Three-Drug Regimen in Treatment-Naïve HIV-1 Positive Adults: A Bayesian Network Meta-Analysis

Introduction: Extensive use of antiretroviral therapy has remarkably improved the survival rates of people living with HIV. Doravirine (DOR) is a newly-approved antiretroviral belonging to the class of non-nucleoside reverse transcriptase inhibitors. Here, we compared the efficacy and safety of DOR...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Ke, Zhang, Yang, Zhou, Jing, Xu, Lulu, Zhou, Chi, Chen, Guanzhi, Huang, Xiaojie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065253/
https://www.ncbi.nlm.nih.gov/pubmed/35517782
http://dx.doi.org/10.3389/fphar.2022.676831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065253/
https://www.ncbi.nlm.nih.gov/pubmed/35517782
http://dx.doi.org/10.3389/fphar.2022.676831

Ejemplares similares